Angiotensin II induces tumor progression and fibrosis in intrahepatic cholangiocarcinoma through an interaction with hepatic stellate cells

International Journal of Oncology

Volumn 37, Issue 5, 2010, Pages 1251-1259

  Okamoto, Koichi ^a   Tajima, Hidehiro ^a   Ohta, Tetsuo ^a   Nakanuma, Shinichi ^a   Hayashi, Hironori ^a   Nakagawara, Hisatoshi ^a   Onishi, Ichiro ^a   Takamura, Hiroyuki ^a   Ninomiya, Itasu ^a   Kitagawa, Hirohisa ^a   Fushida, Sachio ^a   Tani, Takashi ^a   Fujimura, Takashi ^a   Kayahara, Masato ^a   Harada, Shinichi ^a   Wakayama, Tomohiko ^a   Iseki, Shoichi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Angiotensin II; Angiotensin II type 1 receptor; Fibrosis; Hepatic stellate cell; Intrahepatic cholangiocarcinoma

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II; COLLAGEN TYPE 1; GLIAL FIBRILLARY ACIDIC PROTEIN;

ARTICLE; BILE DUCT CARCINOMA; CANCER INVASION; CELL PROLIFERATION; CONTROLLED STUDY; FIBROSIS; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; METASTASIS; PRIORITY JOURNAL; STELLATE CELL; TUMOR GROWTH;

EID: 77957864977     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000776     Document Type: Article

References (43)

1. Kalluri R and Zeisberg M: Fibroblasts in cancer. Nat Rev Cancer 6: 392-401, 2006.
2. Terada T, Ohta T, Minato H and Nakanuma Y: Expression of pancreatic trypsinogen/trypsin and cathepsin B in human cholangiocarcinomas and hepatocellular carcinomas. Hum Pathol 26: 746-752, 1995.
3. Tajima H, Ohta T, Ayman Elnemr, Yasui T, Kitagawa H, Fushida S, Kayahara M, Miwa K, Wakayama T, Iseki S and Yokoyama S: Enhanced invasiveness of pancreatic adenocarcinoma cells stably transfected with cationic trypsinogen cDNA. Int J Cancer 94: 699-704, 2001. (Pubitemid 33035690)
4. Ohta T, Shimizu K, Yi S, Takamura H, Amaya K, Kitagawa H, Kayahara M, Ninomiya I, Fushida S, Fujimura T, Nishimura G and Miwa K: Protease-activated receptor-2 expression and the role of trypsin in cell proliferation in human pancreatic cancers. Int J Oncol 23: 61-66, 2003.
5. Uchima Y and Sawada T: Action of antiproteases on pancreatic cancer cells. J Pancreas 8: 479-487, 2007. (Pubitemid 47263689)
6. Nyberg P, Ylipalosaari M, Sorsa T and Salo T: Trypsins and their role in carcinoma growth. Exp Cell Res 312: 1219-1228, 2006.
7. Arakawa K and Maruta H: Ability of kallikrein to generate angiotensin II-like pressor substance and a proposed 'kinintensin enzyme system'. Nature 25: 705-706, 1980.
8. Ohta T, Amaya K, Yi S, Kitagawa H, Kayahara M, Ninomiya I, Fushida S, Fujimura T, Nishimura G, Shimizu K and Miwa K: Angiotensin converting enzyme-independent, local angiotensin II-generation in human pancreatic ductal cancer tissues. Int J Oncol 23: 593-598, 2003.
9. Amaya K, Ohta T, Kitagawa H, Kayahra M, Takamura H, Fujimura T, Nishimura G, Shimizu K and Miwa K: Angiotensin II activates MAP kinase and NF-κB through angiotensin II type I receptor in human pancreatic cancer cells. Int J Oncol 25: 849-856, 2004.
10. Anandanadesan R, Gong Q, Chipitsyna G, Witkiewicz A, Yeo CJ and Arafat HA: Angiotensin II induces vascular endothelial growth factor in pancreatic cancer cells through an angiotensin II type 1 receptor and ERK1/2 signaling. J Gastrointest Surg 12: 57-66, 2008.
11. Yen TW, Aardal NP, Bronner MP, Thorning DR, Savard CE, Lee SP and Bell RH Jr: Myofibroblasts are responsible for the desmoplastic reaction surrounding human pancreatic carcinomas. Surgery 131: 129-134, 2002.
12. Bachem MG, Schünemann M, Ramadani M, Siech M, Beger H, Buck A, Zhou S, Schmid-Kotsas A and Adler G: Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells. Gastroenterology 128: 907-921, 2005. (Pubitemid 40523543)
13. Tingli J, Liao ZX, Ping J, Xu D and Wang H: Molecular mechanism of hepatic stellate cell activation and antifibrotic therapeutic strategies. J Gastroenterol 43: 419-428, 2008. (Pubitemid 351997878)
14. Gressner AM and Weiskirchen R: Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β as major players and therapeutic targets. J Cell Mol Med 10: 76-99, 2006.
15. Bataller R, Sancho-Bru P, Ginès P and Brenner DA: Liver fibrogenesis: a new role for the renin-angiotensin system. Antioxid Redox Signal 7: 1346-1355, 2005. (Pubitemid 41232532)
16. Svegliati-Baroni G, De Minicis S and Marzioni M: Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition. Liver Int 28: 1052-1064, 2008.
17. Tien YW, Wu YM, Lin WC, Lee HS and Lee PH: Pancreatic carcinoma cells stimulate proliferation and matrix synthesis of hepatic stellate cells. J Hepatol 51: 307-314, 2009.
18. Amann T, Bataille F, Spruss T, Mühlbauer M, Gäbele E, Schölmerich J, Kiefer P, Bosserhoff AK and Hellerbrand C: Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma. Cancer Sci 100: 646-653, 2009.
19. Okabe H, Beppu T, Hayashi H, Horino K, Masuda T, Komori H, Ishikawa S, Watanabe M, Takamori H, Iyama K and Baba H: Hepatic stellate cells may relate to progression of intrahepatic cholangiocarcinoma. Ann Surg Oncol 16: 2555-2564, 2009.
20. Liver Cancer Study Group of Japan: The general rules for the clinical and pathological study of primary liver cancer. 5th edition. Kanehara, Tokyo, pp17-27, 2008.
21. Miyagiwa M, Ichida T, Tokiwa T, Sato J and Sasaki H: A new human cholangiocellular carcinoma cell line (HuCC-T1) producing carbohydrate antigen 19/9 in serum-free medium. In Vitro Cell Dev Biol 25: 503-510, 1989. (Pubitemid 19177403)
22. Sugawara H, Yasoshima M, Katayanagi K, Kono N, Watanabe Y, Harada K and Nakanuma Y: Relationship between interleukin-6 and proliferation and differentiation in cholangiocarcinoma. Histopathology 33: 145-153, 1998. (Pubitemid 28387024)
23. Murakami K, Abe T, Miyazawa M, Yamaguchi M, Masuda T, Matsuura T, Nagamori S, Takeuchi K, Abe K and Kyogoku M: Establishment of a new human cell line, LI90, exhibiting characteristics of hepatic Ito (fat-storing) cells. Lab Invest 72: 731-739, 1995.
24. Isobe A, Takeda T, Sakata M, Miyake A, Yamamoto T, Minekawa R, Nishimoto F, Okamoto Y, Walker CL and Kimura T: Dual repressive effect of angiotensin II-type 1 receptor blocker telmisartan on angiotensin II-induced and estradiol-induced uterine leiomyoma cell proliferation. Hum Reprod 9: 1-7, 2007. (Pubitemid 351651231)
25. Kubota S, Fridman R and Yamada Y: Transforming growth factor-beta suppresses the invasiveness of human fibrosarcoma cells in vitro by increasing expression of tissue inhibitor of metalloprotease. Biochem Biophys Res Commun 176: 129-136, 1991.
26. Morimoto T, Aoyama M, Gotoh E and Shionoiri H: A method of radioimmunoassay of plasma angiotensin II using Florisil. Folia Endocrinoa Jpn 59: 215-229, 1983. (Pubitemid 13052604)
27. Takayanagi R, Ohnaka K, Sakai Y, Nakao R, Yanase T, Haji M, Inagami T, Furuta H, Gou DF, Nakamuta M and Nawata H: Molecular cloning, sequence analysis and expression of a cDNA encoding human type 1 angiotensin II receptor. Biochem Biophys Res Commun 183: 910-906, 1992.
28. Peach MJ: Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev 57: 313-370, 1977.
29. Huckle WR and Earp HS: Regulation of cell proliferation and growth by angiotensin II. Prog Growth Factor Res 5: 177-194, 1994. (Pubitemid 2092591)
30. Escobar E, Rodríguez-Reyna TS, Arrieta O and Sotelo J: Angiotensin II, cell proliferation and angiogenesis regulator: biologic and therapeutic implications in cancer. Curr Vasc Pharmacol 2: 385-399, 2004. (Pubitemid 39200189)
31. Ager EI, Neo J and Christophi C: The renin-angiotensin system and malignancy. Carcinogenesis 29: 1675-1684, 2008.
32. Bours V, Bentires-Alj M, Hellin AC, Viatour P, Robe P, Delhalle S, Benoit V and Merville MP: Nuclear factor-kappa B, cancer, and apoptosis. Biochem Pharmacol 60: 1085-1089, 2000.
33. Lee JU, Hosotani R, Wada M, Doi R, Kosiba T, Fujimoto K, Miyamoto Y, Tsuji S, Nakajima S, Nishimura Y and Imamura M: Role of Bcl-2 family proteins (Bax, Bcl-2 and Bcl-X) on cellular susceptibility to radiation in pancreatic cancer cells. Eur J Cancer 35: 1374-1380, 1999. (Pubitemid 29397439)
34. Ambrosini G, Adida C and Altieri DC: A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3: 917-921, 1997. (Pubitemid 27353455)
35. Asanuma K, Moriai R, Yajima T, Yagihashi A, Yamada M, Kobayashi D and Watanabe N: Survivin as a radioresistance factor in pancreatic cancer. Jpn J Cancer Res 91: 1204-1209, 2000.
36. Salguero Palacios R, Roderfeld M, Hemmann S, Rath T, Atanasova S, Tschuschner A, Gressner OA, Weiskirchen R, Graf J and Roeb E: Activation of hepatic stellate cells is associated with cytokine expression in thioacetamide-induced hepatic fibrosis in mice. Lab Invest 88: 1192-1203, 2008.
37. Morini S, Carotti S, Carpino G, Franchitto A, Corradini SG, Merli M and Gaudio E: GFAP expression in the liver as an early marker of stellate cells activation. Ital J Anat Embryol 110: 193-207, 2005. (Pubitemid 43311980)
38. Wynn TA: Cellular and molecular mechanisms of fibrosis. J Pathol 214: 199-210, 2008.
39. Ishii G, Sangai T, Ito T, Hasebe T, Endoh Y, Sasaki H, Harigaya K and Ochiai A: In vivo and in vitro characterization of human fibroblasts recruited selectively into human cancer stroma. Int J Cancer 117: 212-220, 2005.
40. Mishra PJ, Mishra PJ, Humeniuk R, Medina DJ, Alexe G, Mesirov JP, Ganesan S, Glod JW and Banerjee D: Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res 68: 4331-4339, 2008.
41. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ and Richardson AL, Weinberg RA: Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121: 335-348, 2005. (Pubitemid 40692295)
42. Ohira S, Sasaki M, Harada K, Sato Y, Zen Y, Isse K, Kozaka K, Ishikawa A, Oda K, Nimura Y and Nakanuma Y: Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factor-α and stromal-derived factor-1 released in stroma. Am J Pathol 168: 1155-1168, 2006.
43. Marchesi F, Monti P, Leone BE, Zerbi A, Vecchi A, Piemonti L, Mantovani A and Allavena P: Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4. Cancer Res 64: 8420-8427, 2004. (Pubitemid 39491782)